U.S. Rep. Doris Matsui (D-CA) and Rep. Chris Stewart (R-UT) are finalizing bipartisan legislation to provide temporary 340b program requirement flexibilities to hospitals during the COVID-19 pandemic. The bill will protect hospitals from losing 340b eligibility and waive 340b statutory requirements. Similar legislation sponsored by Sens. John Thune (R-SD), Debbie Stabenow (D-MI), Bob Portman (R-OH), Tammy Baldwin (D-WI) Shelley Moore Capito (R-WV), and Benjamin Cardin (D-MD), S.4160, does not have the 340b hospital waiver. Senators Matsui and Stewart also tried getting the 340b legislation flexibilities passed in the recent HEROES act, but Senate Leaders and the White House are currently negotiating what will be put into the next package. Stewart states that many providers will become ineligible for 340b drug discounts due to the pandemic.

Senators Roger Wicker (R-MS) and Tina Smith (D-MN) introduced bipartisan legislation that would waive Small Business Administration (SBA) affiliation rules for rural hospitals. The bill would allow non-profit critical access hospitals and hospitals that serve rural areas to qualify for Paycheck Protection Program (PPP) loans by removing their SBA affiliation status. The CARES Act established the PPP to provide relief to small businesses with fewer than 500 employees in the form of forgivable loans. Currently, however, many small hospitals operate as part of a larger health system that exceeds the 500-employee limit under SBA’s affiliation rules. The bill would remove this restriction and grant rural hospitals access to the PPP program, allowing them to retain critical staff and provide quality care to patients for the duration of the pandemic. Please continue to contact your Members of Congress on behalf of this important legislation!

Rural Health advocates are helping to advance legislation that would allow struggling rural PPS hospitals to qualify to convert to critical-access hospitals, which would be a lifeline for certain hospitals amid the COVID-19 pandemic. In return, hospitals would limit their beds, services, and length of patient stays. This would allow a limited number of hospitals to get critical-access designation, even if they are less than 35 miles from another hospital. McConnell spoke on the proposal Wednesday, saying he is ‘attuned’ to it but did not explicitly commit to the proposal. McConnell referenced the aid rural hospitals received in the first coronavirus relief package, saying rural health is certainly a focus and will continue to be in the next relief bill. We expect the first draft of the next COVID-19 relief package to come next week.

The Centers for Medicare & Medicaid Services today released its first monthly update of data that provides a snapshot of the impact of COVID-19 on the Medicare population. For the first time, the snapshot includes data for American Indian/Alaskan Native Medicare beneficiaries.

The new data indicate that American Indian/Alaskan Native beneficiaries have the second highest rate of hospitalization for COVID-19 among racial/ethnic groups after Blacks. Previously, the number of hospitalizations of American Indian/Alaskan Native beneficiaries was too low to be reported.

The updated data confirm that the COVID-19 public health emergency is disproportionately affecting vulnerable populations, particularly racial and ethnic minorities. This is due, in part, to the higher rates of chronic health conditions in these populations and issues related to the social determinants of health.

In response to the first Medicare data snapshot and related call to action from CMS Administrator Seema Verma on June 22, the CMS Office of Minority Health hosted three listening sessions with stakeholders who serve and represent racial and ethnic minority Medicare beneficiaries. These sessions provided helpful insight into ways in which CMS can address social risks and other barriers to health care that will help in our efforts to reduce health disparities.

The updated data on COVID-19 cases and hospitalizations of Medicare beneficiaries covers the period from January 1 to June 20, 2020. It is based on Medicare claims and encounter data CMS received by July 17, 2020.

Other key data points:

• Black beneficiaries continue to be hospitalized at higher rates than other racial and ethnic groups, with 670 hospitalizations per 100,000 beneficiaries.
• Beneficiaries eligible for both Medicare and Medicaid – who often suffer from multiple chronic conditions and have low incomes – were hospitalized at a rate more than 4.5 times higher than beneficiaries with Medicare only (719 versus 153 per 100,000).
• Beneficiaries with end-stage renal disease (ESRD) continue to be hospitalized at higher rates than other segments of the Medicare population, with 1,911 hospitalizations per 100,000 beneficiaries, compared with 241 per 100,000 for aged and 226 per 100,000 for disabled.
• CMS paid $2.8 billion in Medicare fee-for-service claims for COVID-related hospitalizations, or an average of $25,255 per beneficiary.

For more information on the Medicare COVID-19 data, visit: https://www.cms.gov/research-statistics-data-systems/preliminary-medicare-covid-19-data-snapshot

 

For an FAQ on this data release, visit: https://www.cms.gov/files/document/medicare-covid-19-data-snapshot-faqs.pdf

CMS hosts varied recurring stakeholder engagement sessions to share information related to the agency’s response to COVID-19. These sessions are open to members of the healthcare community and are intended to provide updates, share best practices among peers, and offer attendees an opportunity to ask questions of CMS and other subject matter experts.

Call details are below. Conference lines are limited so we highly encourage you to join via audio webcast, either on your computer or smartphone web browser. You are welcome to share this invitation with your colleagues and professional networks. These calls are not intended for the press.

Calls recordings and transcripts are posted on the CMS podcast page at: https://www.cms.gov/Outreach-and-Education/Outreach/OpenDoorForums/PodcastAndTranscripts

 

CMS COVID-19 Office Hours Calls (Tuesdays at 5:00 – 6:00 PM Eastern)

Office Hour Calls provide an opportunity for hospitals, health systems, and providers to ask questions of agency officials regarding CMS’s temporary actions that empower local hospitals and healthcare systems to:

• Increase Hospital Capacity – CMS Hospitals Without Walls;
• Rapidly Expand the Healthcare Workforce;
• Put Patients Over Paperwork; and
• Further Promote Telehealth in Medicare

This week’s Office Hours:

Tuesday, July 28^th at 5:00 – 6:00 PM Eastern

Toll Free Attendee Dial In: 833-614-0820; Access Passcode: 1492795

Audio Webcast link: https://protect2.fireeye.com/url?k=c408e7b1-985cce9a-c408d68e-0cc47a6d17cc-d6428ab37156e652&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2297

 

Additional Office Hours:

Tuesday, August 4^th at 5:00 – 6:00 PM Eastern

Toll Free Attendee Dial In: 833-614-0820; Access Passcode: 3296947

Audio Webcast link: https://protect2.fireeye.com/url?k=2d58ded5-710dd705-2d58efea-0cc47a6a52de-a294a2b8484144f1&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2352

 

Tuesday, August 11^th at 5:00 – 6:00 PM Eastern

Toll Free Attendee Dial In: 833-614-0820; Access Passcode: 3498643

Audio Webcast link: https://protect2.fireeye.com/url?k=6f7db93e-3329a042-6f7d8801-0cc47adc5fa2-ed718e46a02e4dc1&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2361

 

Weekly COVID-19 Care Site-Specific Calls

CMS hosts weekly calls for certain types of organizations to provide targeted updates on the agency’s latest COVID-19 guidance. One to two leaders in the field also share best practices with their peers. There is an opportunity to ask questions of presenters if time allows.

Home Health and Hospice (twice a month on Tuesday at 3:00 PM Eastern)

Tuesday, August 11^th at 3:00 – 3:30 PM Eastern

Toll Free Attendee Dial-In: 833-614-0820; Access Passcode: 5097566 Audio Webcast Link: https://protect2.fireeye.com/url?k=b4723cca-e827351a-b4720df5-0cc47a6a52de-e4916e2be973d447&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2386

 

Nursing Homes (twice a month on Wednesday at 4:30 PM Eastern)

Wednesday, August 12^th 4:30 – 5:00 PM Eastern

Toll Free Attendee Dial-In: 833-614-0820; Access Passcode: 7857618 Audio Webcast Link: https://protect2.fireeye.com/url?k=2884bdb1-74d1b4a2-28848c8e-0cc47adb5650-5b54c104cb155c28&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2411

 

Dialysis Organizations (twice a month on Wednesday at 5:30 PM Eastern)

Wednesday, August 12^th at 5:30 – 6:00 PM Eastern

Toll Free Attendee Dial-In: 833-614-0820; Access Passcode: 1027088 Audio Webcast Link: https://protect2.fireeye.com/url?k=6b0af8ba-375ff16a-6b0ac985-0cc47a6a52de-6400b78b7f9a7c65&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2401

 

Nurses (twice a month on Thursdays at 3:00 PM Eastern)

Thursday, August 13^th at 3:00 – 3:30 PM Eastern

Toll Free Attendee Dial-In: 833-614-0820; Access Passcode: 7844289 Audio Webcast Link: https://protect2.fireeye.com/url?k=666e39a3-3a3b30b0-666e089c-0cc47adb5650-9c83dad655df67f4&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2421

 

Lessons from the Front Lines: COVID-19 (twice a month on Fridays at 12:30 – 2:00 PM Eastern)

Lessons from the Front Lines calls are a joint effort between CMS Administrator Seema Verma, FDA Commissioner Stephen Hahn, MD, and the White House Coronavirus Task Force. Physicians and other clinicians are invited to share their experience, ideas, strategies, and insights with one another related to their COVID-19 response. There is an opportunity to ask questions of presenters.

This week’s Lessons from the Front Lines:

Friday, August 7^th at 12:30 – 2:00 PM Eastern

Toll Free Attendee Dial-In: 833-614-0820; Access Passcode: 4695240

Audio Webcast Link: https://protect2.fireeye.com/url?k=c441afa6-9814a6b5-c4419e99-0cc47adb5650-c14a30d0298b73f0&u=https://engage.vevent.com/rt/cms2/index.jsp?seid=2376

 

For the most current information including call schedule changes, please click here

To keep up with the important work the White House Task Force is doing in response to COVID-19 click here: https://protect2.fireeye.com/url?k=36fa2226-6aae0b0d-36fa1319-0cc47a6d17cc-2d06c219f858d641&u=http://www.coronavirus.gov/. For information specific to CMS, please visit the Current Emergencies Website.

EPA has approved more than 460 products that are helping to reduce the spread of COVID-19

The U.S. Environmental Protection Agency (EPA) added 32 new surface disinfectants to List N, the agency’s list of products expected to kill SARS-CoV-2, the novel coronavirus that causes COVID-19.

“Since day one, EPA’s priority has been to provide the public with easy access to the information they need to protect themselves and their families from the virus that causes COVID-19,” said EPA Administrator Andrew Wheeler. “Through our efforts to expand List N, we are ensuring that Americans have a broad set of approved products to clean and disinfect surfaces to help reduce the spread of the coronavirus.”

Disinfectants can qualify for inclusion on List N three ways:

1. The product has been tested against the coronavirus SARS-CoV-2 (COVID-19).
2. The product has demonstrated efficacy against a different coronavirus similar to SARS-CoV-2 (COVID-19).
3. The product has demonstrated efficacy against a pathogen that is harder to kill than SARS-CoV-2 (COVID-19).

EPA has added 32 new products to List-N. These products have already been approved as tuberculocidal. While they have not yet been tested against SARS-CoV-2, they are approved for killing the pathogen that causes tuberculosis and are expected to kill SARS-CoV-2 (COVID-19) when used according to the label (category three noted above).

Many tuberculocidal products are potent disinfectants and have a long history of use for cleaning hospitals and other health care settings. When using such products, it is critical to follow the label directions, including the precautionary statements.

Disinfectant products may be marketed and sold under multiple different brand and product names. Therefore, List N users should use the first two sections of a product’s registration number when searching List N, rather than its brand name. For example, if EPA Reg. No. 12345-12 is on List N, you can buy EPA Reg. No. 12345-12-2567 and know you’re getting an equivalent product. For more information on using an EPA registration number to search List N, see our FAQ at https://www.epa.gov/coronavirus/frequent-questions-about-disinfectants-and-coronavirus-covid-19.

Throughout the COVID-19 public health emergency, EPA has provided the American public with information on disinfecting surfaces against SARS-CoV-2. For more information about EPA’s response to COVID-19 visit: https://www.epa.gov/coronavirus